Univariate and multivariate Cox analyses indicated the FAM64A mRNA expression may be a useful biomarker for pancreatic cancer prognosis, and ROC analysis confirmed the diagnostic value of FAM64A expression in pancreatic cancer. Here, PIMREG is linked to pancreatic neoplasm.